Spero Therapeutics, Inc. (SPRO)

2.285 0.00 (0.00%) USD  |  NASDAQ  |  Dec 16, 16:00
2.285 0.00 (0.00%) After-Hours: 20:00
More

Spero Therapeutics Accounts Payable (Quarterly): 1.395M for Sept. 30, 2025

Accounts Payable (Quarterly) Chart

View Accounts Payable (Quarterly) for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Payable (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Accounts Payable Definition

View Accounts Payable Definition
Start Trial

Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.

Read full definition.

Accounts Payable (Quarterly) Range, Past 5 Years

View Accounts Payable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Payable (Quarterly) Benchmarks

View Accounts Payable (Quarterly) Benchmarks
Start Trial
Omeros Corp. 12.50M
GeoVax Labs, Inc. 0.9764M
Vistagen Therapeutics, Inc. 1.831M
Daré Bioscience, Inc. 1.845M
Hyperion DeFi, Inc. 1.139M